Morepen Laboratories Ltd. today signed
a Marketing JV with Italian diagnostic majors, A.
Menarini to market their world-renowned Menarini
Glucometer range under the Dr. Morepen
brand umbrella in India. Menarini is a pharmaceutical
major established in 1959 and is ranked amongst the top
20 Pharma companies in Europe. In the Self - Diabetes
market Menarini diagnostics has been placed in top five
globally. As per the joint venture agreement, in the first
phase Dr. Morepen would be introducing the Glucometers
from Menarini under the brand "Dr. Morepen
HomeHealth" this would be followed by manufacturing
of these products in India with technological inputs from
the JV partner.
Mr. Sushil Suri, CMD Morepen Laboratories,
said, "This is another momentous step in taking the
brand promise of Dr. Morepen " Health in your hands"
further as now the diabetic patients can monitor their
sugar levels regularly and accurately at home with Glucometers
that have the latest Biosensor technology."
In India, the Homehealth Glucometer would be introduced
in two designs, GlucoMen Glyco and GlucoMen
PC. Both the products are safe and simple to
use with biosensor and electrochemical feature, which
work on the concept of electron capture. The Glucometers
would be priced at Rs. 3995 and Rs.
4850 respectively and they come in vibrant colours
and unique shapes hence fitting the bill of lifestyle
companions perfectly.
GlucoMen Glyco designed with the latest technology currently
available in the market. A patient can get a very precise
test result even at the lowest concentration. There is
a built-in-sensor automatically compensates for changes
in environmental temperature. The quality of the results
is controlled through the use of a check strip. A strip
ejector feature is provided in order to avoid contamination
from the blood. Automatic on/off switch is activated on
insertion or removal of the sensor strip. The Gluco Men
PC also has a strip ejector feature in order to avoid
contamination from the blood, also an optical PC interface
to download the date of the 350 memories and date and
times function and 15 reading averaging function
The worldwide market for self testing of whole blood
glucose products was approximately $4.5 billion in 2000
& is forecast to exceed $5 Billion by 2002 & $8
billion by 2010 at a CAGR of 12%. Where, in India the
market size was pegged at $ 20.29 million in 2000 and
$ 22.95 million in 2001 with a steady growth rate of 13-15%
per annum. Presently the four key players in this business
in the country are Roche, LifeScan, Bayer and Abott with
market share of 41 %, 24%, 14.3% and 8% respectively.
Diabetes is widely recognized as one of the leading causes
of death in most developed countries. The worldwide diabetic
population in 1985 was reported to be 30 million, which
has dramatically risen by almost 500% to 175 million in
2001. According to International Diabetic Federation developing
countries will experience a dramatic increase of 170%
rise by 2025 and the highest rate of increase is expected
to occur in India (+195%).
Back to the
Press Releases Home Page
